Both in Pharmaceuticals
Heron Therapeutics vs Oncolytics Biotech
Over the past year HRTX returned −76.1% and ONCY returned −64.3%; their daily moves had a correlation of 0.08.
HRTX −76.1% ONCY −64.3%Growth of $1, one year, split-adjusted
| Metric | HRTX | ONCY |
|---|---|---|
| Price | $0.2777 | $0.4254 |
| Market cap | $52.7M | $55.8M |
| Today | −5.67% | −0.54% |
| 1 month | −22.0% | −33.7% |
| 6 months | −78.1% | −51.1% |
| Year to date | −78.6% | −51.3% |
| 1 year | −76.3% | −63.6% |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | — |
| Net margin | −14.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | — |
| Net cash | -$100.0M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 115.7% | 63.7% |
| Short % of float | 25.7% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).